Important Dates
Early Bird Registration :6th May 2027
Paper Submission Deadline :11th May 2027
Last Date of Registration : 21st May 2027
Date of Conference : 5th - 6th June 2027
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 10 — Reduced Inequalities
SDG 16 — Peace, Justice and Strong Institutions
Track 01
Pathophysiology of Neurodegenerative Diseases
This session will explore the underlying biological mechanisms that contribute to neurodegenerative diseases. Emphasis will be placed on recent discoveries in cellular and molecular pathways involved in conditions such as Alzheimer's and Parkinson's.
Track 02
Innovative Therapeutic Approaches
This track will focus on novel therapeutic strategies for managing neurodegenerative diseases. Presentations will cover cutting-edge research in drug development, gene therapy, and personalized medicine.
Track 03
Neuroinflammation and Neurodegeneration
This session will examine the role of neuroinflammation in the progression of neurodegenerative diseases. Discussions will highlight the interplay between immune responses and neuronal health.
Track 04
Cognitive Impairment in Neurodegenerative Disorders
This track will delve into the cognitive deficits associated with various neurodegenerative diseases. Research findings on assessment tools and interventions aimed at improving cognitive function will be presented.
Track 05
Biomarkers for Early Diagnosis
This session will focus on the identification and validation of biomarkers for early detection of neurodegenerative diseases. The importance of biomarkers in clinical trials and patient management will also be discussed.
Track 06
Neuroprotective Strategies
This track will explore strategies aimed at protecting neuronal cells from degeneration. Topics will include pharmacological agents, lifestyle interventions, and their implications for patient care.
Track 07
Patient-Centered Approaches in Neurology
This session will emphasize the importance of patient-centered care in the management of neurodegenerative diseases. Discussions will include the integration of patient preferences and experiences into therapeutic decision-making.
Track 08
Advancements in Neuroimaging Techniques
This track will highlight the latest advancements in neuroimaging technologies for studying neurodegenerative diseases. Presentations will focus on how these techniques enhance our understanding of disease progression and treatment efficacy.
Track 09
Genetic and Environmental Risk Factors
This session will investigate the genetic and environmental factors contributing to the risk of developing neurodegenerative diseases. The interplay between genetic predisposition and lifestyle choices will be a key focus.
Track 10
Ethical Considerations in Neurodegenerative Research
This track will address the ethical challenges associated with research in neurodegenerative diseases. Discussions will include informed consent, patient autonomy, and the implications of emerging therapies.
Track 11
Future Directions in Neurodegenerative Disease Research
This session will explore future research directions and emerging trends in the field of neurodegenerative diseases. Participants will discuss potential breakthroughs and the impact of interdisciplinary approaches on therapeutic development.